//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Exploring the potential of psychedelics for the betterment of all. @UC Berkeley
UC Berkeley Center for the Science of Psychedelics









Loading...
The research Michael Silver and his lab are doing at @ucberkeleyofficial.bsky.social not only has the potential to help us better understand the human mind and consciousness, but also to transform the treatment of certain mental illnesses. In this video, he explains in 101 seconds:
In 2023, fewer than half of U.S. voters strongly supported making psychedelics easier for scientists to study. By 2025, that number had risen to 63%. Tyrone Sgambati breaks down the numbers. Learn more about the UC Berkeley Psychedelics Survey on psychedelics.berkeley.edu/survey 📈
Only one third say mental health professionals are “very trustworthy”, while other sources rank even lower. But is there room to build trust? UC Berkeley Psychedelics Survey research scientist Tyrone Sgambati discusses these findings. Learn more: https://bit.ly/42NC6O8
The Microdose reports from the ground of the Interdisciplinary Conference on Psychedelic Research (ICPR), one of Europe's largest psychedelics conferences: https://bit.ly/4uNKjy1
57%. That’s how many U.S. voters reported "proximity" to psychedelics—meaning they’ve either used them or know someone who has. Tyrone Sgambati, PhD breaks down one of the takeaways from our UC Berkeley Psychedelics Survey. Learn more: https://bit.ly/42NC6O8
This week, Veterans Affairs announced a new MDMA clinical trial. Plus, a small trial shows psilocybin’s antidepressant effects are both rapid and long-lasting. Get the latest news in psychedelics on The Microdose: https://bit.ly/4e02QQO
The Microdose speaks to author and mycophile Maria Pinto about retreats for the rich in Jamaica, her experiments with lesser-known psychedelic mushrooms, and the relationship between psychonauts and the broader mycological community. Read the latest 5 Questions: https://bit.ly/4nYfqEt
Join us tomorrow, May 27, as we unpack findings from our latest survey and explore what they mean for policy, research and public understanding. Register now: https://bit.ly/4c1RlHg #webinar #psychedelicsresearch
New @ucberkeleyofficial.bsky.social online summer course open to the public! EDUC 125: Psychedelics Education and the Persistent Taboo on Alternative Ways of Knowing (July 6 – Aug 14) examines how psychedelics are understood, taught and researched. 👉 Enroll now: https://bit.ly/4urm5ZE
Can psychedelics protect the aging brain? In a new study, researchers at @ucberkeleyofficial.bsky.social are exploring whether psilocybin, a compound known to influence brain plasticity, may offer a new avenue to promote healthy aging. Read more: https://bit.ly/4edFCqj
15h
9d
7d
6d
19d
13d
10d
16d
2d
1d
Can psychedelics help our minds and brains stay healthy as we grow older? That’s the question posed by a new first-of-its-kind study launched earlier this year at the UC Berkeley Center for the Scienc...
psychedelics.berkeley.edu
Tripping into Old Age: Can Psychedelics Protect the Aging Brain? - UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
Video
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
UC Berkeley Center for the Science of Psychedelics
Video
Video
Video
Reporting from the Interdisciplinary Conference on Psychedelic Research
bit.ly
Dispatch from The Netherlands
Veterans Affairs announces new MDMA clinical trial; Psilocybin’s antidepressant effects are both rapid and long-lasting
Plus: Psychedelic trips leave traces in speech through vocal “jitter” and “shimmer;" Scientists pair intravenous ketamine with drug targeting opioid receptors to enhance antidepressant effects
bit.ly
bit.ly
2026 Summer EDUC 125 002 LEC 002 | UCB Class Search
Pinto discusses high cost retreats in Jamaica, tensions between mycologists and psychonauts, and her experiences on a little-known hallucinogenic mushroom
Who gets psychedelic access? 5 Questions with author and mycophile Maria Pinto
bit.ly